Nimbus: the Covid-19 variant that may cause ‘razor blade throat'
Advertisement
That is because the variant - NB.1.8.1. or 'Nimbus' - may cause painful sore throats. The symptom has been identified by doctors in the United Kingdom, India and elsewhere, according to media outlets in those countries.
Other Covid-19 symptoms of any variant include fever, chills, cough, shortness of breath or loss of taste or smell.
Experts have said there is not a major cause for concern with the Nimbus variant.
Where the variant is spreading
The rise in cases late last month is primarily in the eastern Mediterranean, Southeast Asia and western Pacific regions, the World Health Organization said on May 28. The new variant had reached nearly 11 per cent of sequenced samples reported globally in mid-May.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South China Morning Post
8 hours ago
- South China Morning Post
How green mango is used in Indian and Thai cuisines, and its medicinal properties
While few people would turn down a juicy, ripe, sweet mango, an unripe one – hard and tart – needs a bit of work to appreciate. Advertisement In Thailand, unripe mango is made into what is known as green mango salad (although the colour of the fruit does not necessarily indicate its ripeness; unripe mango can also have a yellow to reddish tint). For this dish, after being shredded, the mango is mixed with fish sauce, lime juice, sugar, chillies and other flavourings. In Indian cuisine, unripe mango is made into a spice called amchoor (or amchur). The fruit is peeled, sliced and sun-dried, and sometimes ground into a pale beige powder. It tastes intensely tart and is used to add a sour and fruity zestiness to dishes. According to many Indian food websites, amchoor also works as a tenderiser on meat. Thai green mango salad. Photo: Shutterstock In alternative medicine, amchoor is said to be an antioxidant, promote digestion, alleviate anaemia and work as a laxative.
South China Morning Post
a day ago
- South China Morning Post
When experimental treatments lead to death in Hong Kong, prosecution is not always simple
The medical profession is one of the pillars of Hong Kong society and its doctors, as well as other professionals, are expected to, and often do, uphold the highest standards of professional conduct. But a dark corner of the healthcare industry exists in the grey area between medical treatment and experimental procedure. Over the years there have been a number of tragic cases where the administering of experimental treatments has led to the patient's death. As with medical negligence more generally, conduct of this character is prosecuted under the crime of gross negligence manslaughter, which remains a common law offence. In fact, developments in this area of the Hong Kong common law have often come from the medical sector, with the leading case on gross negligence manslaughter being the prosecution of Dr Mak Wan-ling, which led to a decision in 2019 from the Court of Final Appeal that clarified the elements of the offence. Questions were also raised in that series of cases about the legal relationship of the companies running the clinic (also known as the 'DR Group') and whether that was relevant to the law of gross negligence manslaughter. Indeed, these cases may often serve to shine a spotlight on areas where more regulation is required. To clarify the legal responsibilities of other forms of health treatment centres, the government enacted the Private Healthcare Facilities Ordinance (Cap 633) in 2018, which now imposes a number of legal duties on persons who operate private healthcare facilities, clinics and so on.
South China Morning Post
2 days ago
- South China Morning Post
When experimental treatments lead to death, prosecution is not always simple
The medical profession is one of the pillars of Hong Kong society and its doctors, as well as other professionals, are expected to, and often do, uphold the highest standards of professional conduct. But a dark corner of the healthcare industry exists in the grey area between medical treatment and experimental procedure. Over the years there have been a number of tragic cases where the administering of experimental treatments has led to the patient's death. As with medical negligence more generally, conduct of this character is prosecuted under the crime of gross negligence manslaughter, which remains a common law offence. In fact, developments in this area of the Hong Kong common law have often come from the medical sector, with the leading case on gross negligence manslaughter being the prosecution of Dr Mak Wan-ling, which led to a decision in 2019 from the Court of Final Appeal that clarified the elements of the offence. Questions were also raised in that series of cases about the legal relationship of the companies running the clinic (also known as the 'DR Group') and whether that was relevant to the law of gross negligence manslaughter. Indeed, these cases may often serve to shine a spotlight on areas where more regulation is required. To clarify the legal responsibilities of other forms of health treatment centres, the government enacted the Private Healthcare Facilities Ordinance (Cap 633) in 2018, which now imposes a number of legal duties on persons who operate private healthcare facilities, clinics and so on.
